Health update

Test ticker

Monika Bauerlein,
CEO

Dear Reader,

The next few months are make or break for Mother Jones’ fundraising. fundraising, and we need more online readers to pitch in than have been of late. In "It's Not a Crisis. This Is the New Normal," we take a level-headed look at the brutal economics of journalism, why investigative reporting like you get from us matters, and why we're optimistic we can grow our base of support in a big way—starting with hitting a huge $300,000 goal in just three weeks. Please learn more and donate if you can right now.

The next few months are make or break for Mother Jones’ fundraising. We need to raise $300,000 quickly, and we need more online readers to pitch in than have been. Please learn more in "It's Not a Crisis. This Is the New Normal," where we go into the brutal economics of journalism, and what makes Mother Jones unique and worth supporting if you can right now.

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

As I mentioned a couple of weeks ago, my chemo regimen changed last month. The Revlimid reduced my M-protein level for a little while, but then flattened out around 0.6, which is still a long way from zero.¹ So now we’re trying Revlimid plus dexamethasone. Dex is pure evil, but it’s also pretty good at fighting multiple myeloma, so let’s all give a big round of applause to evil! My first test result came back yesterday, and after only three weeks on the dex my M-protein marker has finally budged from 0.6. It’s now down to 0.48. There’s still a long way to go, but at least things are once again moving in the right direction.

¹Standard explainer: myeloma cells produce M-proteins, so measuring them is a good proxy for the level of cancerous cells in my bone marrow. This will never get to zero, but when the M-protein marker reaches zero it means the myeloma is at a very, very low level. So that’s the goal.